JPH0488993A - Production of trans-4, 5-dehydro-l-lysine and producing bacterium thereof - Google Patents
Production of trans-4, 5-dehydro-l-lysine and producing bacterium thereofInfo
- Publication number
- JPH0488993A JPH0488993A JP20416590A JP20416590A JPH0488993A JP H0488993 A JPH0488993 A JP H0488993A JP 20416590 A JP20416590 A JP 20416590A JP 20416590 A JP20416590 A JP 20416590A JP H0488993 A JPH0488993 A JP H0488993A
- Authority
- JP
- Japan
- Prior art keywords
- dehydro
- lysine
- trans
- nocardiopsis
- culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 11
- 241000894006 Bacteria Species 0.000 title claims description 9
- 239000004472 Lysine Substances 0.000 claims abstract description 12
- 241000203622 Nocardiopsis Species 0.000 claims abstract description 9
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims abstract description 4
- 241001221335 Nocardiopsis sp. Species 0.000 claims abstract description 4
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims 1
- 238000012258 culturing Methods 0.000 abstract description 5
- 150000001875 compounds Chemical class 0.000 abstract description 4
- 239000003429 antifungal agent Substances 0.000 abstract description 2
- 229940121375 antifungal agent Drugs 0.000 abstract description 2
- 239000002609 medium Substances 0.000 description 15
- 238000000034 method Methods 0.000 description 12
- XDEFUBWPXAOAME-OWOJBTEDSA-N (e)-2,6-diaminohex-4-enoic acid Chemical compound NC\C=C\CC(N)C(O)=O XDEFUBWPXAOAME-OWOJBTEDSA-N 0.000 description 10
- 229920001817 Agar Polymers 0.000 description 10
- 239000008272 agar Substances 0.000 description 10
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 9
- 239000000049 pigment Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 244000005700 microbiome Species 0.000 description 6
- 229910052799 carbon Inorganic materials 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000013076 target substance Substances 0.000 description 5
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- XLYOFNOQVPJJNP-ZSJDYOACSA-N Heavy water Chemical compound [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
- 241001468274 Saccharothrix mutabilis Species 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 230000002378 acidificating effect Effects 0.000 description 4
- 235000011114 ammonium hydroxide Nutrition 0.000 description 4
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 4
- 239000001913 cellulose Substances 0.000 description 4
- 229920002678 cellulose Polymers 0.000 description 4
- 238000012136 culture method Methods 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 4
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 3
- 244000068988 Glycine max Species 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 238000000862 absorption spectrum Methods 0.000 description 3
- 230000000843 anti-fungal effect Effects 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 239000003729 cation exchange resin Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 210000002421 cell wall Anatomy 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 235000013312 flour Nutrition 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 235000002639 sodium chloride Nutrition 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- GMKMEZVLHJARHF-UHFFFAOYSA-N (2R,6R)-form-2.6-Diaminoheptanedioic acid Natural products OC(=O)C(N)CCCC(N)C(O)=O GMKMEZVLHJARHF-UHFFFAOYSA-N 0.000 description 2
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 2
- WFIYPADYPQQLNN-UHFFFAOYSA-N 2-[2-(4-bromopyrazol-1-yl)ethyl]isoindole-1,3-dione Chemical compound C1=C(Br)C=NN1CCN1C(=O)C2=CC=CC=C2C1=O WFIYPADYPQQLNN-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 2
- 229920005654 Sephadex Polymers 0.000 description 2
- 239000012507 Sephadex™ Substances 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 239000012458 free base Substances 0.000 description 2
- 229930182830 galactose Natural products 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- -1 hydrochloric acid Chemical class 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- GMKMEZVLHJARHF-SYDPRGILSA-N meso-2,6-diaminopimelic acid Chemical compound [O-]C(=O)[C@@H]([NH3+])CCC[C@@H]([NH3+])C([O-])=O GMKMEZVLHJARHF-SYDPRGILSA-N 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 230000000877 morphologic effect Effects 0.000 description 2
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 229910000160 potassium phosphate Inorganic materials 0.000 description 2
- 235000011009 potassium phosphates Nutrition 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 235000020183 skimmed milk Nutrition 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- BBBFYZOJHSYQMW-LGDQNDJISA-N (2s)-2,4-diamino-4-oxobutanoic acid;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal Chemical compound OC(=O)[C@@H](N)CC(N)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O BBBFYZOJHSYQMW-LGDQNDJISA-N 0.000 description 1
- DPEYHNFHDIXMNV-UHFFFAOYSA-N (9-amino-3-bicyclo[3.3.1]nonanyl)-(4-benzyl-5-methyl-1,4-diazepan-1-yl)methanone dihydrochloride Chemical group Cl.Cl.CC1CCN(CCN1Cc1ccccc1)C(=O)C1CC2CCCC(C1)C2N DPEYHNFHDIXMNV-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 241000186361 Actinobacteria <class> Species 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 241000905957 Channa melasoma Species 0.000 description 1
- 229910021580 Cobalt(II) chloride Inorganic materials 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000549343 Myadestes Species 0.000 description 1
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 108010093965 Polymyxin B Proteins 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- 241000576755 Sclerotia Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- VJHCJDRQFCCTHL-UHFFFAOYSA-N acetic acid 2,3,4,5,6-pentahydroxyhexanal Chemical compound CC(O)=O.OCC(O)C(O)C(O)C(O)C=O VJHCJDRQFCCTHL-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 238000005377 adsorption chromatography Methods 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- PNNNRSAQSRJVSB-BXKVDMCESA-N aldehydo-L-rhamnose Chemical compound C[C@H](O)[C@H](O)[C@@H](O)[C@@H](O)C=O PNNNRSAQSRJVSB-BXKVDMCESA-N 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 235000011116 calcium hydroxide Nutrition 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- GVPFVAHMJGGAJG-UHFFFAOYSA-L cobalt dichloride Chemical compound [Cl-].[Cl-].[Co+2] GVPFVAHMJGGAJG-UHFFFAOYSA-L 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 229910000042 hydrogen bromide Inorganic materials 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 230000015784 hyperosmotic salinity response Effects 0.000 description 1
- 239000003978 infusion fluid Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- FBAFATDZDUQKNH-UHFFFAOYSA-M iron chloride Chemical compound [Cl-].[Fe] FBAFATDZDUQKNH-UHFFFAOYSA-M 0.000 description 1
- 229910000358 iron sulfate Inorganic materials 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 229940049018 mycostatin Drugs 0.000 description 1
- MHWLWQUZZRMNGJ-UHFFFAOYSA-N nalidixic acid Chemical compound C1=C(C)N=C2N(CC)C=C(C(O)=O)C(=O)C2=C1 MHWLWQUZZRMNGJ-UHFFFAOYSA-N 0.000 description 1
- 229960000210 nalidixic acid Drugs 0.000 description 1
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 1
- 239000006916 nutrient agar Substances 0.000 description 1
- VQOXZBDYSJBXMA-NQTDYLQESA-N nystatin A1 Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 VQOXZBDYSJBXMA-NQTDYLQESA-N 0.000 description 1
- 239000006877 oatmeal agar Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 1
- 229920000024 polymyxin B Polymers 0.000 description 1
- 229960005266 polymyxin b Drugs 0.000 description 1
- 239000001965 potato dextrose agar Substances 0.000 description 1
- SSOLNOMRVKKSON-UHFFFAOYSA-N proguanil Chemical compound CC(C)\N=C(/N)N=C(N)NC1=CC=C(Cl)C=C1 SSOLNOMRVKKSON-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 238000011218 seed culture Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000002336 sorption--desorption measurement Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 235000015113 tomato pastes and purées Nutrition 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 241001446247 uncultured actinomycete Species 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は、抗真菌剤として有用なトランス−4゜5−デ
ヒドロ−し−リジンの新規な製造法及びこれを生産する
微生物に関する。DETAILED DESCRIPTION OF THE INVENTION [Field of Industrial Application] The present invention relates to a novel method for producing trans-4.5-dehydro-lysine useful as an antifungal agent and a microorganism that produces the same.
トランス−4,5−デヒドロ−DL−リジンは公知化合
物であり、例えばJ、Chem、 Sac、 Perk
in r19721B25に記載の方法で合成できる。Trans-4,5-dehydro-DL-lysine is a known compound, for example J, Chem, Sac, Perk.
It can be synthesized by the method described in in r19721B25.
また、特開昭63−183526号公報には、このトラ
ンス−4,5−デヒドロ−DL−リジン、特にトランス
−4,5−デヒドロ−し−リジンが優れた抗真菌作用を
示すこと、及びDL一体から効率的にL一体を得る方法
が記載されている。Furthermore, JP-A-63-183526 discloses that this trans-4,5-dehydro-DL-lysine, especially trans-4,5-dehydro-lysine, exhibits excellent antifungal activity and that DL-lysine exhibits excellent antifungal activity. A method for efficiently obtaining L-integral from an integral is described.
しかしながら、このトランス−4,5−デヒドロ−L−
!Jリジン製造法は、ラセミ化合物中から光学分割によ
りD一体を除去するものであるため、最終工程でのL体
の収率を50%以上にすることは理論上不可能であり、
工業的に有利な方法ではなかった。However, this trans-4,5-dehydro-L-
! Since the J-lysine production method involves removing the D-isomer from the racemic compound by optical resolution, it is theoretically impossible to increase the yield of the L-isomer in the final step to 50% or more.
It was not an industrially advantageous method.
従って、優れた抗真菌作用を有するトランス−4,5−
デヒドロ−し−リジンを工業的に有利に製造する方法の
開発が望まれていた。Therefore, trans-4,5-
It has been desired to develop an industrially advantageous method for producing dehydro-lysine.
斯かる実情において、本発明者らは鋭意検討を重ねた結
果、ノカルジオプシス属に属する特定の菌が、特異的に
トランス−4,5−デヒドロ−L−リジンを生産するこ
とを見出し、本発明を完成した。Under these circumstances, the present inventors have conducted intensive studies and found that a specific bacterium belonging to the genus Nocardiopsis specifically produces trans-4,5-dehydro-L-lysine, and has devised the present invention. completed.
すなわち本発明は、ノカルジオプシス属に属するトラン
ス−4,5−デヒドロ−L−リジン生産菌を培養し、得
られた培養液よりトランス−4,5−デヒドロ−し−リ
ジンを採取することを特徴とするトランス−4,5−デ
ヒドロ−し−リジンの製造法及びこれを生産する微生物
を提供するものである。That is, the present invention is characterized by culturing trans-4,5-dehydro-L-lysine-producing bacteria belonging to the genus Nocardiopsis, and collecting trans-4,5-dehydro-lysine from the resulting culture solution. The present invention provides a method for producing trans-4,5-dehydro-lysine and a microorganism that produces the same.
本発明のトランス−4,5−デヒドロ−し−リジンを生
産する微生物としては、例えばノカルジオプシス・エス
ピー KC−7223が挙げられる。このKC−722
3株は次のような菌学的性質を有する。なお各種培地上
の性質は特に記載のない限り、27℃で14日間培養し
、常法によって観察したものであり、色調の表現はカラ
ー・ハーモニー・マニュアル544版(コンテナー・コ
ーポレーション・アメリカ)の分類に従った。Examples of microorganisms that produce trans-4,5-dehydro-lysine of the present invention include Nocardiopsis sp. KC-7223. This KC-722
The three strains have the following mycological properties. Unless otherwise specified, properties on various media were observed using conventional methods after culturing at 27°C for 14 days, and color expressions were based on the classification of Color Harmony Manual, 544th edition (Container Corporation America). I followed.
■、形態学的性質
本菌株は数種の培地上で貧弱であるが、気菌糸を形成す
る。それらは単純分枝し、胞子槽は気菌糸上に枝状に生
じ、その先端は直状あるいは部分的に波状を呈する。(2) Morphological properties Although this strain is poor on several types of media, it forms aerial mycelia. They are simply branched, and the sporophores occur in the form of branches on the aerial hyphae, and their tips are straight or partially wavy.
胞子は短円筒形で0.3 X 1.0μm程度の大きさ
を示し、20個以上の連鎖をなす。胞子表面は平滑構造
を有する。鞭毛胞子、胞子のう、菌核などの形成は認め
られず、長生菌子の分断は認められた。The spores are short cylindrical, approximately 0.3 x 1.0 μm in size, and form chains of 20 or more. The spore surface has a smooth structure. Formation of flagellated spores, sporangia, sclerotia, etc. was not observed, and fragmentation of long-living mycelium was observed.
■、各種培地上の性状
1、シュクロース・硝酸塩寒天培地
生育:良好
気菌糸の着生:認められない
気菌糸の色:認められない
長生菌糸の色:微黄色(24!c)
可溶性色素:微黄色(21c)
2、グルコース・アスパラギン寒天培地生育:中程度
気菌糸の着生:認められない
気菌糸の色:認められない
長生菌糸の色:淡灰桃色(3c a)
可溶性色素:微黄色(24!c)
3、グリセリン・アスパラギン寒天培地生育:良好
気菌糸の着生:認められない
気菌糸の色:認められない
長生菌糸の色:微黄色(2ea)
可溶性色素:微黄色(2l c)
4、スターチ・無機塩寒天培地
生育:良好
気菌糸の着生:貧弱
気菌糸の色:白(a)
長生菌糸の色:微黄白色(2c a)
可溶性色素:認められない
5、チロシン寒天培地
生育:中程度
気菌糸の着生:認められない
気菌糸の色:認められない
長生菌糸の色:淡灰褐色(3ec)
可溶性色素:認められない
6、栄養寒天培地
生育:中程度
気菌糸の着生:詔められない
気菌糸の色:認められない
長生菌糸の色:微黄白色(2ca)
可溶性色素:認められない
7、イースト・麦芽寒天培地
生育:良好
気菌糸の着生:貧弱
気菌糸の色:白(a)
長生菌糸の色:微黄白色(2ca)
可溶性色素:微黄色(21c)
8、オートミール寒天培地
生育:中程度
気菌糸の着生:認められない
気菌糸の色:認められない
長生菌糸の色:白(a)
可溶性色素:認められない
■、生理的性質
1、生育温度範囲 15℃〜40℃至適生育温度
30℃〜36℃
2、ゼラチンの液化 陰 性3、 スターチ
の加水分解 陽 性4、脱脂牛乳の凝固
陽 性脱脂牛乳のペプトン化 陽 性
5、 メラニン様色素の生成 陰 性6、耐塩性
≦4%
■、炭素源の利用性
プリドハム・ボッ) IJ−ブ寒天培地上での炭素源の
利用性を検討した結果、L−アラビノース、D−キシロ
ース、D−グルコース、D−フラクトース、シュクロー
ス及びラフィノースを利用した。■, Properties on various media 1, Sucrose/nitrate agar medium Growth: Good Adhesion of aerial mycelium: Not observed Color of aerial hyphae: Not observed Color of long hyphae: Slight yellow (24!c) Soluble pigment: Slight yellow (21c) 2. Glucose-asparagine agar medium Growth: Moderate Aerial hyphae settlement: Not observed Color of aerial hyphae: Not observed Color of long hyphae: Pale gray pink (3c a) Soluble pigment: Slight yellow (24!c) 3. Glycerin/asparagine agar medium Growth: Good Aerial mycelial settlement: Not observed Color of aerial hyphae: Not observed Color of long hyphae: Slight yellow (2ea) Soluble pigment: Slight yellow (2l c) ) 4. Starch/Inorganic Salt Agar Medium Growth: Good Aerial Mycelia Adhesion: Poor Aerial Mycelia Color: White (a) Long Mycelia Color: Slight yellowish white (2c a) Soluble pigment: Not observed 5. Tyrosine Agar Growth on medium: Moderate Aerial hyphae growth: Not observed Color of aerial hyphae: Not observed Color of long-growing hyphae: Pale gray brown (3ec) Soluble pigment: Not observed 6, Growth on nutrient agar medium: Moderate aerial hyphae Growth on yeast/malt agar medium: Good Growth on yeast/malt agar medium: Poor Aerial mycelium growth: Poor Color of aerial hyphae: White (a) Color of long hyphae: Slight yellowish white (2ca) Soluble pigment: Slight yellow (21c) 8. Growth on oatmeal agar medium: Moderate Adhesion of aerial hyphae: Not observed Color of aerial hyphae : Not observed Color of long-growing hyphae: White (a) Soluble pigment: Not observed ■, Physiological properties 1, Growth temperature range 15°C to 40°C Optimal growth temperature 30°C to 36°C 2, Liquefaction of gelatin Negative 3. Hydrolysis of starch Positive 4. Coagulation of skim milk
Positive Peptonization of skim milk Positive 5, Production of melanin-like pigment Negative 6, Salt tolerance
≦4% ■、Carbon source availability (Pridham Bot) As a result of examining the availability of carbon sources on IJ-bu agar medium, L-arabinose, D-xylose, D-glucose, D-fructose, and sucrose were found. and raffinose were used.
D−マンニトールの利用は認められなかった。イノシト
ール、L−ラムノースの利用は疑わしかった。The use of D-mannitol was not allowed. The use of inositol and L-rhamnose was questionable.
■、細胞壁成分 1、細胞壁加水分解中のジアミノピメリン酸の分析 meso−ジアミノピメリン酸を含む。■、Cell wall components 1. Analysis of diaminopimelic acid during cell wall hydrolysis Contains meso-diaminopimelic acid.
2、細胞壁加水分解中の糖成分の分析
マジュロース、ガラクトース、アラビノース及びキシロ
ースを含まない。2. Analysis of sugar components during cell wall hydrolysis Contains no madulose, galactose, arabinose or xylose.
以上の形態的特徴並びに生理的性質をもとに本菌株と類
似する菌株を「バーシーズ・マニュ7JL。Based on the above-mentioned morphological characteristics and physiological properties, a strain similar to this strain was designated as "Bercy's Manu 7JL".
・オブ・デターミナテイブ・バクテリオロジー」第8版
、シャーリング及びゴツトリーブによるISP記載の諸
菌株及びワックスマン著「ジ・了りチノミセテス」第2
巻及びその他の放線菌の新種発表文献を検索したところ
類似株ノカルジオプシス・ムタビリス(Nocardi
opsis mutabilis IFO14310)
株が選択された。``Of Determinative Bacteriology'' 8th edition, Schirling and Gottlieb's ISP-described bacterial strains, and Waxman's ``The Perfect Chinomycetes'' Vol. 2
A search for publications on new species of actinomycetes and other actinomycete species revealed similar strains, Nocardiopsis mutabilis (Nocardiopsis mutabilis).
opsis mutabilis IFO14310)
Stocks were selected.
しかし、ノカルジオプシス・ムタビリスIF01431
0株(以下rN、m株」という)は、全菌体糖成分とし
て、ガラクトースを含有するがKC−7223株は含有
しない。又、N、 m株はラフィノースを利用しないが
、にC−7223株は利用する等の点で両菌株は異なっ
ていた。以上より、KC−7223株はノカルジオプシ
ス・ムタビリスに近縁な新規菌株と判断し、ノカルジオ
プシス・sp、KC−7223株と命名し、工業技術院
微生物工業技術研究所に微工研条寄第2993号(FE
!RM −BP−2993)として寄託した。However, Nocardiopsis mutabilis IF01431
Strain 0 (rN, hereinafter referred to as "strain m") contains galactose as a whole cell sugar component, but strain KC-7223 does not. In addition, the two strains differed in that the N and m strains did not utilize raffinose, while the C-7223 strain did. Based on the above, the KC-7223 strain was determined to be a new strain closely related to Nocardiopsis mutabilis, and was named Nocardiopsis sp. (FE
! RM-BP-2993).
本発明においては、ノカルジオプシス属に属し、トラン
ス−4,5−デヒドロ−し−リジンの生産能を有する菌
であれば、上記KC−7223株だけでなく、その自然
変異株、人工変異株も使用することができることはいう
までもない。In the present invention, not only the above-mentioned strain KC-7223 but also its natural mutants and artificial mutants can be used, as long as they belong to the genus Nocardiopsis and have the ability to produce trans-4,5-dehydro-lysine. It goes without saying that you can.
上記の本発明微生物を用いてトランス−4,5−デヒド
ロ−し−リジンを得るには、適当な培地に本発明微生物
を接種し、通常の抗生物質生産のための培養方法に従っ
て培養すればよい。培地としては、資化し得る窒素源と
炭素源を適宜組み合わせて含有せしためものが使用され
る。この炭素源及び窒素源には特に制限はなく、例えば
炭素源としては、澱粉、ブドウ糖、グリセリン、マルト
ース、デキストリン、蔗糖、果糖、糖蜜など;更に菌の
資化性によっては、炭化水素、有機酸なども用いること
ができる。これらは単独でも二種以上を混合して用いて
もよい。一方、窒素源としては大豆粉、酵母エキス、乾
燥酵母、ペプトン、肉エキス、コーンステイープリカー
、カザミノ酸、ディスティラーズソリニプル、塩化アン
モニウム、硫酸アンモニウム、尿素、硝酸ナトリウムな
どが単独で又は組み合わせて用いられる。In order to obtain trans-4,5-dehydro-cy-lysine using the above-mentioned microorganism of the present invention, the microorganism of the present invention may be inoculated into an appropriate medium and cultured according to the usual culture method for antibiotic production. . As the medium, one containing an appropriate combination of assimilable nitrogen sources and carbon sources is used. There are no particular restrictions on the carbon and nitrogen sources; examples of carbon sources include starch, glucose, glycerin, maltose, dextrin, sucrose, fructose, and molasses; etc. can also be used. These may be used alone or in combination of two or more. On the other hand, as nitrogen sources, soybean flour, yeast extract, dried yeast, peptone, meat extract, cornstarch liquor, casamino acids, distiller's solitaire, ammonium chloride, ammonium sulfate, urea, sodium nitrate, etc. are used alone or in combination. It will be done.
その他必要に応じ、食塩、燐酸カリウム、硫酸マグネシ
ウム、塩化カルシウム、炭酸カルシウム、水酸化カルシ
ウム、塩化コバルト、硫酸亜鉛、塩化鉄、硫酸鉄、リン
酸カリウム、リン酸ナトリウムなどの無機塩、並びに微
量の重金属を添加することができる。さらに菌の発育を
助け、トランス−4,5−デヒドロ−し−リジンの生産
を促進する有機及び無機物質を適宜に添加することがで
きる。Other inorganic salts such as common salt, potassium phosphate, magnesium sulfate, calcium chloride, calcium carbonate, calcium hydroxide, cobalt chloride, zinc sulfate, iron chloride, iron sulfate, potassium phosphate, sodium phosphate, and trace amounts of Heavy metals can be added. Furthermore, organic and inorganic substances that aid the growth of bacteria and promote the production of trans-4,5-dehydro-lysine can be added as appropriate.
通気培養法を用いる場合には、さらに脂肪油、シリコー
ン油、パラフィンなどの消泡剤が用いられる。When using the aerated culture method, an antifoaming agent such as fatty oil, silicone oil, paraffin, etc. is further used.
培養方法としては、固体培地上での培養も可能であるが
、一般抗生物質生産の方法と同様に液体培養法、特に深
部培養法を用いることが好ましい。As a culture method, although culture on a solid medium is also possible, it is preferable to use a liquid culture method, particularly a deep culture method, as in the general antibiotic production method.
培養は好気的条件下で行なわれ、培養温度は20〜35
℃、特に25〜30℃が好ましい。振盪培養又はタンク
培養のいずれの場合も2〜6日間培養を行なうと、活性
物質が培養液中に生産蓄積される。培養液中の生産量が
最大に達した時点で培養を停止し、培養液中より目的の
抗生物質を単離精製する。Cultivation is carried out under aerobic conditions, with a culture temperature of 20-35
℃, especially 25 to 30℃ is preferred. When culture is carried out for 2 to 6 days, whether in shaking culture or tank culture, the active substance is produced and accumulated in the culture medium. The culture is stopped when the production amount in the culture solution reaches the maximum, and the antibiotic of interest is isolated and purified from the culture solution.
培養濾液から本物質を単離精製するには、目的とする物
質が水に可溶で一般の有機溶媒に難溶の水溶性塩基性物
質であるため、通常の水溶性塩基性抗生物質の単離、精
製法を利用することができる。このためイオン交換樹脂
、活性炭、セルロース、シリカゲル、アルミナ等による
吸脱着法、補助剤として高級脂肪酸を加えブタノール、
アミルアルコール等で抽出する方法などを適当に組み合
わせて用いることができる。To isolate and purify this substance from the culture filtrate, the target substance is a water-soluble basic substance that is soluble in water and sparingly soluble in common organic solvents. Separation and purification methods can be used. For this purpose, adsorption/desorption methods using ion exchange resins, activated carbon, cellulose, silica gel, alumina, etc., butanol,
An appropriate combination of methods such as extraction with amyl alcohol or the like can be used.
培養濾液を弱酸性陽イオン交換樹脂の層に通すと、目的
物質が吸着される。これを0.1〜3.0規定のアルカ
リ又は酸で溶出し、活性成分を凍結乾燥すると、目的物
質の粗粉末が得られる。このとき用いられる弱酸性陽イ
オン交換樹脂としては、アンバーライト IRC−50
、I RC−84又1tcG−50(ローム・アンド・
ハース社製)、ダイヤイオンWK−10又はWK−20
(三菱化成社製)などがあげられる。またアルカリとし
てはアンモニア水、水酸化す)IJウム水溶液などが、
酸としては蟻酸、塩酸、硫酸などがあげられる。When the culture filtrate is passed through a layer of weakly acidic cation exchange resin, the target substance is adsorbed. This is eluted with a 0.1 to 3.0 normal alkali or acid, and the active ingredient is lyophilized to obtain a coarse powder of the target substance. The weakly acidic cation exchange resin used at this time is Amberlite IRC-50.
, I RC-84 or 1tcG-50 (ROHM & Co., Ltd.)
(manufactured by Haas), Diamondion WK-10 or WK-20
(manufactured by Mitsubishi Kasei Corporation). In addition, as alkalis, ammonia water, hydroxide, IJium aqueous solution, etc.
Examples of acids include formic acid, hydrochloric acid, and sulfuric acid.
培養濾液をpH7〜9に調整し、目的物質を活性炭に吸
着させ、酸性の水又は塩酸メタノールで溶出させる方法
も利用できる。A method can also be used in which the culture filtrate is adjusted to pH 7 to 9, the target substance is adsorbed on activated carbon, and the target substance is eluted with acidic water or hydrochloric acid and methanol.
こうして得られる粗粉末は、弱酸性陽イオン交換樹脂、
CM−セファデックス、CM−セルロースなどに吸着さ
せ、アンモニア水、蟻酸アンモニウム水溶液などを用い
、濃度勾配法又は濃度段階法で溶出することにより、目
的物が遊離塩基として得られる。The coarse powder obtained in this way is a weakly acidic cation exchange resin,
The target product can be obtained as a free base by adsorbing it onto CM-Sephadex, CM-cellulose, etc., and eluting with aqueous ammonia, aqueous ammonium formate, etc. by a concentration gradient method or a concentration step method.
単離された目的物は、更にセルロース、シリカゲル、ア
ルミナなどを用いる吸着クロマトグラフィー、セファデ
ックスG−10などを用いるゲル濾過法、ダウエックス
1×2などを用いるイオン交換クロマトグラフィー、高
速液体クロマトグラフィーなどを適用することによって
精製することができる。これらの方法は単独で又は組み
合せて適用することができる。The isolated target product is further processed by adsorption chromatography using cellulose, silica gel, alumina, etc., gel filtration method using Sephadex G-10, etc., ion exchange chromatography using Dowex 1x2, etc., and high performance liquid chromatography. It can be purified by applying etc. These methods can be applied alone or in combination.
こうして得られる遊離塩基は、更に無機酸例えば塩酸、
硫酸、臭化水素酸又は有機酸例えば酢酸、しゅう酸、メ
タンスルホン酸などを加え、常法により酸付加塩に導く
ことができる。The free base thus obtained can be further treated with an inorganic acid such as hydrochloric acid,
An acid addition salt can be obtained by adding sulfuric acid, hydrobromic acid or an organic acid such as acetic acid, oxalic acid, methanesulfonic acid, etc. in a conventional manner.
本発明によれば、トランス−4,5−デヒドロ−し−リ
ジンを特異的に生産する微生物を用い、これを培養する
ことにより優れた抗真菌作用を有するトランス−4,5
−デヒドロ−L−リジンを効率よく生産することができ
る。According to the present invention, by using a microorganism that specifically produces trans-4,5-dehydro-lysine and culturing it, trans-4,5-dehydro-lysine, which has an excellent antifungal effect, is produced.
-Dehydro-L-lysine can be efficiently produced.
以下、実施例を挙げ、本発明を更に詳しく説明するが、
本発明はこれらに限定されるものではない。Hereinafter, the present invention will be explained in more detail with reference to Examples.
The present invention is not limited to these.
実施例1
埼玉県深谷市で採取した土壌試料を、滅菌水に懸濁させ
、これを、ポテト浸出液(ポテト10%、トマトペース
ト0.5%、オートミル1%)に肉エキス0.1%、マ
イコスタチン50μg/m!、ペニシリンGO14μg
/ml、ポリミキシンB2μg/−、ナリジキシン酸8
μg/rnl及び寒天1.5%を加えた培地(pH7,
0)に塗抹し、27℃で7日間培養を行い、生じた集落
を採取することによって、トランス−4,5−デヒドロ
−L−リジン生産菌(ノカルジオプシス・sp、 KC
−7223)を得た。Example 1 A soil sample collected in Fukaya City, Saitama Prefecture was suspended in sterilized water, and this was mixed with potato infusion solution (10% potato, 0.5% tomato paste, 1% oatmeal), 0.1% meat extract, Mycostatin 50μg/m! , penicillin GO 14μg
/ml, polymyxin B 2μg/-, nalidixic acid 8
Medium containing μg/rnl and 1.5% agar (pH 7,
Trans-4,5-dehydro-L-lysine producing bacteria (Nocardiopsis sp, KC
-7223) was obtained.
実施例2
ポテト・デキストロース寒天斜面に生育したノカルジオ
プシス・sp、KC−7223株を可溶性澱粉1%、グ
ルコース1%、大豆粉1.5%、KH,PO。Example 2 Nocardiopsis sp, KC-7223 strain grown on a potato dextrose agar slope was treated with 1% soluble starch, 1% glucose, 1.5% soybean flour, KH, PO.
0.27%、Na、HPO40,18%、MgSO4・
7H200,05%及びCoCl2 ・6H−00,0
005%からなる培地に接種し、28℃で72時間振盪
培養して種培養液とした。0.27%, Na, HPO40.18%, MgSO4・
7H200,05% and CoCl2 6H-00,0
005% and cultured with shaking at 28° C. for 72 hours to obtain a seed culture.
次いで、グルコース2%、大豆粉1%、肉エキス0.2
%、酵母エキス0.2%、Mg5O1・7H,00,0
5%、CoCf2・6H,OO,0005%及び綿実油
0.5%からなる培地151を30f容量のステンレス
タンク中に仕込み、この培地中に前記の種培養液100
−を接種し、通気量51/分、攪拌数300r、 p、
m、、28℃で72時間培養した。Next, glucose 2%, soybean flour 1%, meat extract 0.2
%, yeast extract 0.2%, Mg5O1.7H,00,0
A medium 151 consisting of 5% CoCf2.6H, OO, 0005% and 0.5% cottonseed oil was placed in a stainless steel tank with a capacity of 30 f.
- inoculated, aeration rate 51/min, stirring number 300 r, p,
The cells were cultured at 28°C for 72 hours.
培養終了後、培養液を濾過し、得られた濾液(2OA)
をアンバーライトI RC−50[H”:NH,+型(
1: 4) :]のカラム(11)に吸着し、水洗後0
.5Nアンモニア水で溶出した。活性区分を集め、減圧
下濃縮後、CM−セファデックスC−25(NH4+型
)のカラム(100rnl)に吸着させ、水〜0.2N
アンモニア水で濃度勾配溶出を行った。活性画分を集め
、減圧下濃縮後、濃縮液をセルロースカラム(2001
ff)の上部に載せ、メタノール:水:6N−塩酸:ピ
リジン(40: 13: 2 : 5)の溶媒系で溶出
分画した。活性画分を濃縮し、pHを5に調整後、水を
展開溶媒とするセファデックスG−10のカラムクロマ
トグラフィー(300ml)で精製し、凍結乾燥して無
色の粉末(60■)を得た。After culturing, the culture solution was filtered and the obtained filtrate (2OA)
Amberlite I RC-50 [H”: NH, + type (
1: 4) :] adsorbed on the column (11), and after washing with water, 0
.. It was eluted with 5N ammonia water. The active fraction was collected, concentrated under reduced pressure, adsorbed on a column (100 rnl) of CM-Sephadex C-25 (NH4+ type), and mixed with water to 0.2N
Concentration gradient elution was performed with aqueous ammonia. The active fractions were collected and concentrated under reduced pressure, and the concentrated solution was passed through a cellulose column (2001
ff) and eluted and fractionated with a solvent system of methanol:water:6N-hydrochloric acid:pyridine (40:13:2:5). After concentrating the active fraction and adjusting the pH to 5, it was purified by Sephadex G-10 column chromatography (300 ml) using water as a developing solvent, and lyophilized to obtain a colorless powder (60 ml). .
得られた物質の理化学的性質は下記のとおりである。The physical and chemical properties of the obtained substance are as follows.
1、比旋光度(塩酸塩);
〔α〕=5−5.7° (c 0.7 、 H2O)2
、紫外線吸収スペクトル;
末端吸収を示すのみである。1. Specific rotation (hydrochloride); [α] = 5-5.7° (c 0.7, H2O)2
, UV absorption spectrum; shows only terminal absorption.
3、赤外線吸収スペクトル;
臭化水素ペレット中で測定したスペクトルは図1に示す
とおりである。3. Infrared absorption spectrum; The spectrum measured in hydrogen bromide pellets is as shown in Figure 1.
4、 ’It−NMR;
重水中で測定した’H−NMRスペクトルは図2に示す
とおりである。4. 'It-NMR; The 'H-NMR spectrum measured in heavy water is as shown in FIG. 2.
5、 ”C−NMR;
重水中で測定した” C−NMRスペクトルは図3に示
すとおりである。5. "C-NMR; Measured in heavy water" The C-NMR spectrum is as shown in FIG. 3.
以下余白
6、 薄層クロマトグラフィー;
(デイフコ社製)に被験菌の懸濁液を塗抹して、27℃
で2〜4日間培養して測定した。Margin 6 below: Thin layer chromatography: (manufactured by Difco) is smeared with a suspension of the test bacteria and incubated at 27°C.
The cells were cultured for 2 to 4 days and measured.
プレート:セルロースプレート
Art、 5718(メルク社製)
7、呈色反応;
ニンヒドリン反応及びライドンスミス反応に陽性である
。Plate: Cellulose plate Art, 5718 (manufactured by Merck & Co.) 7. Color reaction; Positive for ninhydrin reaction and Lydon-Smith reaction.
以上の理化学的性質より、本物質はトランス−4,5−
デヒドロ−し−リジンであることが確認された。From the above physical and chemical properties, this substance is trans-4,5-
It was confirmed to be dehydro-lysine.
試験例1
実施例2で得られたトランス−4,5−デヒドロ−L−
!Jリジン真菌に対する最小発育阻止濃度(MIC)を
測定したところ以下の通りであった。なお測定は、イー
ストモルフォロジー寒天プレートTest Example 1 Trans-4,5-dehydro-L- obtained in Example 2
! The minimum inhibitory concentration (MIC) against J-lysine fungi was measured and was as follows. The measurement was performed using a yeast morphology agar plate.
図1は本発明物質の赤外線吸収スペクトル、図2ハ1H
−NMRスヘクトル、図3 ft13C−NMRスペク
トルを示す。
以上Figure 1 shows the infrared absorption spectrum of the material of the present invention, Figure 2C1H
-NMR spectrum, Figure 3 shows the ft13C-NMR spectrum. that's all
Claims (1)
ドロ−L−リジン生産菌を培養し、得られた培養液より
トランス−4,5−デヒドロ−L−リジンを採取するこ
とを特徴とするトランス−4,5−デヒドロ−L−リジ
ンの製造法。 2、ノカルジオプシス属に属するトランス−4,5−デ
ヒドロ−L−リジン生産菌。 3、ノカルジオプシス・エスピー (Nocardiopsissp.)KC−7223で
ある請求項2記載のトランス−4,5−デヒドロ−L−
リジン生産菌。[Claims] 1. Cultivating trans-4,5-dehydro-L-lysine producing bacteria belonging to Nocardiopsis and collecting trans-4,5-dehydro-L-lysine from the resulting culture solution. Characteristic method for producing trans-4,5-dehydro-L-lysine. 2. A trans-4,5-dehydro-L-lysine producing bacterium belonging to the genus Nocardiopsis. 3. The trans-4,5-dehydro-L- according to claim 2, which is Nocardiopsis sp. KC-7223.
Lysine producing bacteria.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP20416590A JPH0488993A (en) | 1990-08-01 | 1990-08-01 | Production of trans-4, 5-dehydro-l-lysine and producing bacterium thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP20416590A JPH0488993A (en) | 1990-08-01 | 1990-08-01 | Production of trans-4, 5-dehydro-l-lysine and producing bacterium thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH0488993A true JPH0488993A (en) | 1992-03-23 |
Family
ID=16485914
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP20416590A Pending JPH0488993A (en) | 1990-08-01 | 1990-08-01 | Production of trans-4, 5-dehydro-l-lysine and producing bacterium thereof |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0488993A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5669781A (en) * | 1993-06-24 | 1997-09-23 | Ishida; Nobuaki | Cartridge connection mechanism |
-
1990
- 1990-08-01 JP JP20416590A patent/JPH0488993A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5669781A (en) * | 1993-06-24 | 1997-09-23 | Ishida; Nobuaki | Cartridge connection mechanism |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH0488993A (en) | Production of trans-4, 5-dehydro-l-lysine and producing bacterium thereof | |
US4550021A (en) | Antitumor antibiotic 81-484 and process for its production | |
CA2041237C (en) | Ucf1 compounds derivatives thereof and processes for their preparation | |
JPH0213677B2 (en) | ||
JPS5920359B2 (en) | Production method of polylysine | |
JPS61141889A (en) | Novel antibiotic sf-2197b and its preparation | |
EP0050961B1 (en) | Novel antibiotics, a process for producing the same, medical compositions containing the same, and a novel strain of the genus streptomyces for use in producing the same | |
JP2854671B2 (en) | New substance UCF1 | |
JPH0547560B2 (en) | ||
JPH0488992A (en) | Production of 4-oxo-l-lysine and producing bacterium thereof | |
JP3474601B2 (en) | FO-1611A, B and / or FO-1611C substances and method for producing the same | |
JP2858939B2 (en) | Antibiotics AB3217A, AB3217B and AB3217C and their production | |
JPH0321158B2 (en) | ||
AU620595B2 (en) | Process for the preparation of macrolide compounds | |
US4316957A (en) | Process for the production of 7-deazaadenosine and 7-deazainosine | |
JPH05279374A (en) | Suidatrestin and its production | |
JPS60248190A (en) | Preparation of phosphinothericin | |
JPH0631311B2 (en) | Antibiotics RK-1061A, RK-1061B, and RK-1061C and method for producing the same | |
JPS5849237B2 (en) | Method for producing dientamicin C/a | |
JPS60199396A (en) | Production of isoflavone derivative | |
JPH05111387A (en) | Production of cis-4-hydroxy-l-proline | |
JPS6212798B2 (en) | ||
JPH01101893A (en) | Production of substance fr-66979 | |
JPS5995897A (en) | Preparation of antibiotic substance | |
JPS6310999B2 (en) |